+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

-Rejection of an allogeneic bone marrow graft following successful treatment of severe graft-versus-host disease (GVHD)



-Rejection of an allogeneic bone marrow graft following successful treatment of severe graft-versus-host disease (GVHD)



Japanese Journal of Clinical Hematology 37(2): 134-138



A 38-year-old female with acute myelogenous leukemia (M2) received an allogeneic bone marrow graft from an HLA-DR one locus-mismatched sister during the first remission. The conditioning regimen consisted of busulfan and cyclophosphamide. Acute graft-versus-host disease (GVHD) developed on day 11 after transplantation. Although the GVHD was successfully treated with methylprednisolone, peripheral blood neutrophils that had begun to increase disappeared in association with improvement of the GVHD and graft rejection was eventually diagnosed. The second bone marrow transplantation from the same donor ended up with engraftment failure. She died of sepsis due to Candida albicans following the development of Epstein-Barr virus-associated B-lymphoproliferative disorder. The clinical course of this patient indicates that successful therapy of severe GVHD with methylprednisolone may lead to marrow graft rejection.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045010682

Download citation: RISBibTeXText

PMID: 8852031


Related references

Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients. Blood 101(9): 3741-3748, 2003

Severe ocular graft versus host disease (GVHD): association with mortality in allogeneic bone marrow transplant (BMT) patients with severe systemic GVHD. Journal of American Association for Pediatric Ophthalmology and Strabismus 18(4): E16-E17, 2014

Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients. Journal of Immunology 166(5): 3174-3183, 2001

The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT). Experimental Hematology 23(14): 1667-1675, 1995

Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice. Zhonghua Xue Ye Xue Za Zhi 33(2): 88-93, 2012

Ligation of OX40 regulates graft-versus-host disease and graft rejection in allogeneic bone marrow transplant recipients. Blood 101(9): 3741-3748, May1, 2003

Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase. Bone Marrow Transplantation 20(11): 945-952, 1997

Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation. Transplantation 57(10): 1474-1479, 1994

Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complement. Blood 69(2): 388-393, 1987

Prevention of graft versus host disease gvhd following allogeneic marrow transplantation bmt appears to abrogate the antileukemic immunologic surveillance of the marrow graft. Journal of Cellular Biochemistry Suppl. (11 Part D): 108, 1987

Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood 67(3): 811-816, 1986

Successful Treatment with Prednisone of Graft-Versus-Host Disease in an Allogeneic Bone-Marrow Transplant Recipient. European Journal of Haematology 22(4): 333-338, 1979

Successful treatment with prednisone and graft-versus-host disease in an allogeneic bone-marrow transplant recipient. Scandinavian Journal of Haematology 22(4): 333-338, 1979

Successful Treatment of Chronic Graft-versus-Host Disease with Sulfasalazine in Allogeneic Bone Marrow Transplantation. Acta Haematologica 102(2): 107-109, 1999

Successful treatment of chronic graft-versus-host disease with sulfasalazine in allogeneic bone marrow transplantation. Acta Haematologica 102(2): 107-109, 1999